A Randomized, Repeat Dose, Open Label, Parallel Group, Multi-center Study to Evaluate the Effect of Daprodustat Compared to Darbepoetin Alfa on Forearm Blood Flow in Participants With Anemia of Chronic Kidney Disease That Are Not Dialysis Dependent
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 31 Jul 2018
At a glance
- Drugs Daprodustat (Primary) ; Acetylcholine; Darbepoetin alfa; Sodium nitroprusside
- Indications Anaemia
- Focus Pharmacodynamics
- Acronyms FBF-CKD
- Sponsors GlaxoSmithKline
- 23 Jul 2018 Planned End Date changed from 4 Oct 2019 to 21 Oct 2019.
- 23 Jul 2018 Planned primary completion date changed from 4 Oct 2019 to 21 Oct 2019.
- 23 Jul 2018 Planned initiation date changed from 17 Jul 2018 to 1 Aug 2018.